Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

CorVel Corp Stock Research

CRVL

198.00USD+1.35(+0.69%)Market Closed
Watchlist

Market Summary

USD198.00+1.35
Market Closed
0.69%

CRVL Alerts

  • 1 major insider sales recently.

CRVL Stock Price

CRVL RSI Chart

CRVL Valuation

Market Cap

3.4B

Price/Earnings (Trailing)

48.44

Price/Sales (Trailing)

4.59

EV/EBITDA

28.77

Price/Free Cashflow

51.07

CRVL Price/Sales (Trailing)

CRVL Profitability

EBT Margin

11.77%

Return on Equity

32.83%

Return on Assets

16.85%

Free Cashflow Yield

1.96%

CRVL Fundamentals

CRVL Revenue

Revenue (TTM)

732.5M

Revenue Y/Y

7.91%

Revenue Q/Q

2.59%

CRVL Earnings

Earnings (TTM)

69.5M

Earnings Y/Y

18.66%

Earnings Q/Q

9%

Price Action

52 Week Range

135.81228.94
(Low)(High)

Last 7 days

3.1%

Last 30 days

-10.0%

Last 90 days

1.6%

Trailing 12 Months

40.8%

CRVL Financial Health

Current Ratio

1.45

CRVL Investor Care

Buy Backs (1Y)

2.24%

Diluted EPS (TTM)

3.97

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for CRVL

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-15
CLEMONS V GORDON
sold
-1,000,080
200
-5,000
chairman of the board
2023-08-31
CLEMONS V GORDON
sold
-224,620
220
-1,021
chairman of the board
2023-08-30
CLEMONS V GORDON
sold
-215,380
220
-979
chairman of the board
2023-08-29
CLEMONS V GORDON
sold
-216,000
216
-1,000
chairman of the board
2023-08-24
CLEMONS V GORDON
sold
-220,000
220
-1,000
chairman of the board
2023-08-15
Shishin Maxim
sold
-527,107
224
-2,346
chief information officer
2023-08-15
Shishin Maxim
acquired
139,165
59.32
2,346
chief information officer
2023-08-15
HAMERSLAG STEVEN J
sold
-1,784,910
223
-8,000
-
2023-08-14
CLEMONS V GORDON
sold
-662,138
220
-3,000
chairman of the board
2023-08-11
CLEMONS V GORDON
sold
-440,000
220
-2,000
chairman of the board

1–10 of 50

Which funds bought or sold CRVL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-20
BARCLAYS PLC
added
8.13
85,000
929,000
-%
2023-08-23
WOLVERINE TRADING, LLC
sold off
-100
-241,000
-
-%
2023-08-22
COMERICA BANK
new
-
3,000
3,000
-%
2023-08-21
OSAIC HOLDINGS, INC.
unchanged
-
556
33,282
-%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
5.95
39,000
555,000
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-3.34
-37,555
2,168,360
-%
2023-08-16
GTS SECURITIES LLC
new
-
201,433
201,433
0.01%
2023-08-16
Nuveen Asset Management, LLC
added
2.7
299,558
7,056,560
-%
2023-08-15
ALLIANCEBERNSTEIN L.P.
unchanged
-
38,447
2,310,390
-%
2023-08-15
LAZARD ASSET MANAGEMENT LLC
reduced
-87.72
-66,000
9,000
-%

1–10 of 50

Latest Funds Activity

Are funds buying CRVL calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CRVL
No. of Funds

Schedule 13G FIlings of CorVel

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
clemons v gordon
7.74%
1,330,534
SC 13G/A
Feb 14, 2023
corstar holdings, inc.
37.3%
6,414,036
SC 13G/A
Feb 14, 2023
kayne anderson rudnick investment management llc
11.01%
1,901,500
SC 13G/A
Feb 13, 2023
renaissance technologies llc
4.33%
744,610
SC 13G/A
Feb 09, 2023
vanguard group inc
6.41%
1,106,807
SC 13G/A
Jan 25, 2023
blackrock inc.
8.7%
1,507,366
SC 13G/A
Feb 14, 2022
kayne anderson rudnick investment management llc
11.27%
1,997,505
SC 13G/A
Feb 14, 2022
clemons v gordon
7.87%
1,389,837
SC 13G/A
Feb 11, 2022
renaissance technologies llc
5.11%
902,210
SC 13G/A
Feb 10, 2022
corstar holdings, inc.
36.8%
6,494,036
SC 13G/A

Recent SEC filings of CorVel

View All Filings
Date Filed Form Type Document
Sep 19, 2023
4
Insider Trading
Aug 31, 2023
4
Insider Trading
Aug 28, 2023
4
Insider Trading
Aug 21, 2023
144
Notice of Insider Sale Intent
Aug 17, 2023
4
Insider Trading
Aug 17, 2023
4/A
Insider Trading
Aug 15, 2023
4
Insider Trading
Aug 15, 2023
8-K
Current Report
Aug 15, 2023
4
Insider Trading
Aug 15, 2023
144
Notice of Insider Sale Intent

Peers (Alternatives to CorVel)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
467.4B
348.5B
2.58% -0.25%
22.14
1.34
13.69% 15.63%
91.1B
186.1B
1.20% 2.75%
13.64
1.92
3.72% 22.38%
65.7B
98.7B
2.37% -0.92%
23.41
0.71
10.45% 7.48%
37.6B
147.9B
9.82% -11.33%
13.86
0.25
7.12% 45.86%
MID-CAP
6.3B
937.9M
7.27% 5.79%
487.64
6.67
17.97% 120.64%
5.2B
2.3B
3.17% 35.63%
86.23
2.28
2.85% -58.05%
3.4B
732.5M
-10.01% 40.81%
48.44
4.59
9.34% 4.86%
3.2B
4.4B
-5.13% -20.02%
10.13
0.74
-16.06% -30.43%
2.8B
6.5B
-3.58% 23.39%
13.3
0.44
1.83% 10.70%
SMALL-CAP
1.9B
1.5B
-14.60% 38.53%
-147.84
1.25
12.20% -155.34%
1.4B
999.1M
-4.77% -10.44%
25.66
1.38
10.42% 21.37%
779.3M
3.0B
-1.19% -3.50%
-7.56
0.26
11.66% -12.20%

CorVel News

Defense World
Maryland State Retirement & Pension System Reduces Position in ....
Defense World,
6 days ago
StockNews.com
Marketscreener.com
CorVel Announces First Generative AI Module.
Marketscreener.com,
20 days ago
GlobeNewswire
Yahoo Finance
13 Best Low Float Stocks to Buy.
Yahoo Finance,
3 months ago
GlobeNewswire
CorVel Announces Revenues and Earnings.
GlobeNewswire,
4 months ago

Returns for CRVL

Cumulative Returns on CRVL

17.8%


10-Year Cumulative Returns

26.3%


7-Year Cumulative Returns

26.7%


5-Year Cumulative Returns

32.3%


3-Year Cumulative Returns

Risks for CRVL

What is the probability of a big loss on CRVL?

44.6%


Probability that CorVel stock will be more than 20% underwater in next one year

30%


Probability that CorVel stock will be more than 30% underwater in next one year.

17.7%


Probability that CorVel stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CRVL drawdown profile look like?

Y-axis is the maximum loss one would have experienced if CorVel was unfortunately bought at previous high price.

Drawdowns

Financials for CorVel

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue1.9%733719704690670646620597576553554561572592596594595596588583571
Gross Profit1.3%160158159154155152145140134124119117119126128128127125119116110
  S&GA Expenses-3.0%71.0074.0071.0071.0070.0068.0067.0067.0066.0064.0064.0064.0065.0065.0066.0065.0063.0063.0062.0062.0061.00
EBITDA-100.0%-11011310810910810198.0092.0083.0078.0069.0074.0083.0085.00------
EBITDA Margin-100.0%-0.15*0.16*0.16*0.16*0.17*0.16*0.16*0.16*0.15*0.14*0.12*0.13*0.14*0.14*------
Earnings Before Taxes5.0%89.0085.0088.0084.0085.0085.0078.0074.0069.0059.0055.0053.0054.0061.0062.0063.0063.0062.0057.0053.0049.00
EBT Margin-100.0%-0.12*0.13*0.12*0.13*0.13*0.13*0.12*0.12*0.11*0.10*0.09*0.09*0.10*0.10*------
Net Income4.7%69.0066.0068.0065.0066.0066.0062.0059.0055.0046.0043.0041.0042.0047.0047.0048.0048.0047.0044.0043.0039.00
Net Income Margin-100.0%-0.09*0.10*0.09*0.10*0.10*0.10*0.10*0.10*0.08*0.08*0.07*0.07*0.08*0.08*------
Free Cashflow-100.0%-56.0056.0040.0051.0037.0049.0068.0073.0077.0070.0052.0042.0048.0044.00------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets6.0%418394408400416415424425422425458442425416422427428318314310291
  Current Assets9.9%268244257248261265269272267269259242224209211219222215210204183
    Cash Equivalents21.4%87.0071.0078.0076.0094.0098.0011613113914012910694.0083.0090.0098.0010492.0096.0090.0073.00
  Net PPE1.8%84.0083.0082.0083.0084.0076.0071.0070.0071.0071.0072.0072.0074.0076.0077.0072.0068.0062.0063.0065.0067.00
  Goodwill0%37.0037.0037.0037.0037.0037.0037.0037.0037.0037.0037.0037.0037.0037.0037.0037.0037.0037.0037.0037.0037.00
Liabilities9.8%211192213202210203209201193204248239227227229226224123121120109
  Current Liabilities11.8%188168186176181171171163152162159149139134136133131117117116105
Shareholder's Equity2.4%207202195198206212215224230220210202198190193201204195192190182
  Retained Earnings2.7%751732713697682665646632616599584573561553541531519505493483470
  Additional Paid-In Capital1.3%221219211208205202199196192186180176171169166164161156153149146
Shares Outstanding-0.3%17.0017.0017.0017.0018.0018.0018.0018.0018.0018.0018.0018.0018.0018.0018.0018.0019.0019.0019.0019.0019.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations8.0%89.0082.0086.0072.0083.0067.0071.0090.0093.0094.0088.0074.0070.0081.0077.0076.0082.0079.0080.0080.0064.00
  Share Based Compensation-1.2%5.006.005.005.005.005.005.005.005.005.004.004.004.004.005.005.004.004.004.004.003.00
Cashflow From Investing12.7%-22.99-26.32-30.54-31.60-31.74-29.82-22.39-21.92-20.10-17.24-17.91-21.75-27.94-32.36-32.71-26.34-20.33-15.27-21.66-22.73-25.36
Cashflow From Financing10.4%-73.62-82.14-93.30-95.63-95.40-79.61-61.91-43.15-28.78-20.64-31.19-43.98-52.25-56.96-51.18-42.35-30.77-27.42-15.63-5.420.00
  Buy Backs-9.5%85.0094.0010010310390.0076.0058.0044.0033.0040.0052.0059.0066.0060.0052.0041.0035.0023.0011.003.00

CRVL Income Statement

2023-06-30
Consolidated Income Statements - Unaudited - USD ($)
3 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]  
REVENUES$ 190,253,000$ 176,307,000
Cost of revenues148,375,000136,438,000
Gross profit41,878,00039,869,000
General and administrative expenses16,450,00018,671,000
Income before income tax provision25,428,00021,198,000
Income tax provision5,623,0004,507,000
NET INCOME$ 19,805,000$ 16,691,000
Net income per common and common equivalent share  
Basic$ 1.16$ 0.95
Diluted$ 1.14$ 0.94
Weighted average common and common equivalent shares  
Basic17,144,00017,506,000
Diluted17,385,00017,803,000

CRVL Balance Sheet

2023-06-30
Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Mar. 31, 2023
Current Assets  
Cash and cash equivalents$ 86,593,000$ 71,329,000
Customer deposits84,755,00080,022,000
Accounts receivable, net84,176,00081,034,000
Prepaid taxes and expenses12,426,00011,385,000
Total current assets267,950,000243,770,000
Property and equipment, net84,276,00082,770,000
Goodwill36,814,00036,814,000
Other intangibles, net1,139,0001,244,000
Right-of-use asset, net26,119,00027,721,000
Deferred tax asset, net552,000224,000
Other assets723,0001,380,000
TOTAL ASSETS417,573,000393,923,000
Current Liabilities  
Accounts and taxes payable20,419,00015,309,000
Accrued liabilities167,312,000152,578,000
Total current liabilities187,731,000167,887,000
Long-term lease liabilities22,862,00023,860,000
Total liabilities210,593,000191,747,000
Commitments and contingencies
Stockholders' Equity  
Common stock, $.0001 par value: 120,000,000 shares authorized at June 30, 2023 and March 31, 2023; 55,019,773 shares issued (17,113,915 shares outstanding, net of Treasury shares) and 54,987,366 shares issued (17,169,500 shares outstanding, net of Treasury shares) at June 30, 2023 and March 31, 2023, respectively3,0003,000
Paid-in capital221,486,000218,700,000
Treasury stock (37,905,858 shares at June 30, 2023 and 37,817,866 shares at March 31, 2023)(765,982,000)(748,195,000)
Retained earnings751,473,000731,668,000
Total stockholders' equity206,980,000202,176,000
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$ 417,573,000$ 393,923,000
Michael G. Combs
3680
CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. It also provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company was incorporated in 1987 and is headquartered in Fort Worth, Texas.